Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion type Assertion NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_head.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion description "[As a result, therapy with CL-14-NY-ESO-1 together with anti-CTLA-4 is highly effective in controlling the development of an established melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_provenance.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion evidence source_evidence_literature NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_provenance.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion SIO_000772 25403749 NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_provenance.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion wasDerivedFrom befree-2016 NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_provenance.
- NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_assertion wasGeneratedBy ECO_0000203 NP1238038.RANR2ssc_91y6JId-7GuNU72AXAANiL9QH3H3quarX4w0130_provenance.